UrgoStart Contact
Urgo Medical
Description
Flexible lipido-colloid non-occlusive contact layer containing TLC-NOSF Healing Matrix that jellifies in contact with wound exudate, reducing MMP levels and restoring balance to close wounds sooner. NICE 2019 medical technology guidance (MTG42) states that evidence supports the case for adopting UrgoStart dressings to treat diabetic foot ulcers and venous leg ulcers.
Indications
Non-exuding to low-exuding wounds, including leg ulcers, diabetic foot ulcers, pressure ulcers and long-standing acute wounds. Suitable for lining cavities or awkwardly placed wounds and for wicking deep wounds. Use with a secondary absorbent dressing for exuding wounds.
Contraindications
Do not use on infected or critically colonised wounds, cancerous wounds and fistulas that may reveal a deep abscess, or if there is a known sensitivity to the dressing
Price
5×7cm, £3.13; 10×10cm, £4.42; 15×20cm, £10.56
More on: Protease modulators